Skip to content
left end
left end
right end

Safety reporting (adverse events)

Throughout the course of your study it is important to ensure appropriate reporting arrangements are in place for recording adverse and serious adverse events.

Adverse events

An adverse event is any untoward medical occurrence in a subject to whom a medicinal product/medical device/intervention has been administered, including occurrences which are not necessarily caused by or related to that product/device/intervention.

An event/reaction is serious if it:

  • results in death
  • is life threatening
  • results in persistent or significant disability/incapacity
  • requires hospitalisation
  • prolongs a current hospitalisation
  • results in a congenital anomaly or birth defect

Once an event has been classified as serious (an SAE), an assessment needs to be made by the Principal Investigator (PI) or delegated individual in the PIs absence as to whether the event is related to the study treatment/intervention and an 'unexpected' event. If an event is both related and unexpected it becomes a SUSAR - Suspected Unexpected Serious Adverse Reaction. These events need to be reported to the Sponsor immediately and the provisions for reporting will be detailed in the Protocol (which should also contain a list of 'expected' events). Depending on whether an event is an SAE or SUSAR, there are specific reporting requirements with urgent timelines that must be met. More information on these can be found in our Standard Operating Procedure (SOP) outlined below. If you are still unsure of your requirements please contact the R&I office and ask to speak to a member of the monitoring team on 0117 34 20233.

For the Research Safety Reporting Standard Operating Procedure, please refer to the SOPs page.

Template forms which can be used to report adverse events can be found on the Templates page here. If UH Bristol is the Sponsor then use of these forms is mandatory.

See the SOP page and the Templates page for more information.